Literature DB >> 10580408

Lack of differences in nef alleles among HIV-infected asymptomatic long-term survivors and those who progressed to disease.

D V Mourich1, S Lee, G Reyes-Teran, C E Mackewicz, J A Levy.   

Abstract

Sequences of the human immunodeficiency virus (HIV) nef gene in virus isolates from 12 long-term survivors (LTSs) and 7 progressors were compared to determine if any association existed between the sequences and the corresponding clinical status. The sequences of at least five clones were determined for each subject. Conceptual translations of the open reading frames (ORFs) were examined with respect to a consensus with a prototypic nef sequence (HIV-1SF2) and for conservation of functionally described motifs. Premature stops were observed at equivalent, yet low, frequencies among the different clinical groups: 2 of 60 (3.33%) and 1 of 45 (2.22%) respectively. No remarkable differences in protein motifs implicated in several activities ascribed to Nef were noted. An association between nef sequence characteristics and the clinical state was not found.

Entities:  

Mesh:

Year:  1999        PMID: 10580408     DOI: 10.1089/088922299309865

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression.

Authors:  Ravindra Pushker; Jean-Marc Jacqué; Denis C Shields
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

2.  Comparison of transcriptional profiles between CD4+ and CD8+ T cells in HIV type 1-infected patients.

Authors:  Chaoyu Xu; Baochun Ye; Zongping Han; Mingxing Huang; Yujia Zhu
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-17       Impact factor: 2.205

3.  An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers.

Authors:  Jiwei Ding; Ling Ma; Jianyuan Zhao; Yongli Xie; Jinming Zhou; Xiaoyu Li; Shan Cen
Journal:  J Transl Med       Date:  2019-01-21       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.